What is Cardax, Inc. (CDXI) stock price today?

Cardax, Inc. (CDXI) is currently trading at $0.00.

What is CDXI P/E ratio?

Cardax, Inc.'s P/E ratio is 0.00. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is CDXI return on equity (ROE)?

Cardax, Inc.'s return on equity (ROE) is 50.00%, indicating how efficiently the company generates profit from shareholders' equity. This is considered high quality.

What is Cardax, Inc.'s market cap?

Cardax, Inc. has a market capitalization of $80.

OTC · Biotechnology

Cardax, Inc. (CDXI) Stock

$0.00 OTC: CDXI Healthcare

Valuation

Metric	Value
Price	$0.00
Market Cap	$80
P/E Ratio	0.00
P/B Ratio	0.00
P/S Ratio	0.00
EPS (TTM)	$-0.65
52-Week High	$0.00
52-Week Low	$0.00
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	50.00%
ROA	-112.56%
ROCE	33.56%
Gross Margin	65.75%
Operating Margin	-737.57%
Net Margin	-500.00%
Debt/Equity	-0.50
Current Ratio	0.09

Annual Financials (USD)

Metric	2016	2017	2018	2019	2020
Revenue	$0	$1.0M	$2.0M	$1.0M	$1.0M
Operating Profit	$-2.0M	$-2.0M	$-4.0M	$-4.0M	$-3.0M
Net Profit	$-2.0M	$-2.0M	$-4.0M	$-5.0M	$-5.0M
EPS	$-4.68	$-3.97	$-6.32	$-8.40	$-6.79
Op Margin	-5190.9%	-328.1%	-266.2%	-573.5%	-568.3%

Balance Sheet (USD)

Metric	2016	2017	2018	2019	2020
Total Assets	$1.0M	$3.0M	$2.0M	$2.0M	$1.0M
Total Liabilities	$5.0M	$5.0M	$6.0M	$9.0M	$12.0M
Cash	$0	$2.0M	$0	$0	$0
Borrowings	$0	$0	$0	$3.0M	$5.0M

Cash Flow (USD)

Metric	2016	2017	2018	2019	2020
Operating Cash Flow	$-1.0M	$-2.0M	$-3.0M	$-4.0M	$-2.0M
Investing Cash Flow	$0	$0	$0	$0	$0
Financing Cash Flow	$0	$0	$0	$0	$0
Net Cash Flow	$0	$2.0M	$-2.0M	$0	$0
Free Cash Flow	$-1.0M	$-2.0M	$-3.0M	$-4.0M	$-2.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	0.00
EV / EBITDA	-1.81
FCF Yield	-2257745.00%
Quick Ratio	0.01
Interest Coverage	-1.28
Return 1Y	0.00%
Return 3Y	-50.00%
Return 5Y	—

Ownership

Insiders Held0.00%

Institutions Held0.00%

Institutions Float Held0.00%

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
ELOXEloxx Pharmaceuticals, Inc.	$10.78	-9.72%	-2.05	$81.64M	0.00%
LGBICannabiz Mobile, Inc.	$0.00	—	-86.42	$505	0.00%
MDVLQMedAvail Holdings, Inc.	$0.00	—	-0.05	$161	0.00%
MICRDMicron Solutions, Inc.	$0.00	—	0.00	$317	0.00%
MODCModern Technology Corp.	$0.00	—	0.01	$1102	0.00%

About Cardax, Inc.

Cardax, Inc. is a biopharmaceutical enterprise focused on both creating and marketing nutritional supplements for maintaining inflammatory well-being, as well as developing pharmaceutical treatments for chronic ailments rooted in inflammation and oxidative stress. Its product portfolio includes ZanthoSyn, an advanced supplement for inflammation, health, and longevity that delivers astaxanthin with superior absorption and purity. This product is primarily distributed through online sales and wholesale channels. The company is also progressing two pharmaceutical candidates: CDX-101, an astaxanthin-derived drug candidate intended to address cardiovascular inflammation and dyslipidemia, with a primary focus on severe hypertriglyceridemia; and CDX-301, a zeaxanthin-based pharmaceutical currently under development for macular degeneration. Cardax, Inc. maintains its headquarters in Honolulu, Hawaii.

Cardax, Inc. (CDXI) stock trades at $0.00 with a market capitalization of $80. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.00, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.

On profitability, Cardax, Inc. generates a return on equity (ROE) of 50.00% — well above the market average, a sign of a high-quality business, return on capital employed of 33.56%, an operating margin of -737.57%, a net profit margin of -500.00%.

Official website: www.cardaxpharma.com

Related Healthcare Stocks

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks All stock screens

Run Stock Screener Investing Guides